Literature DB >> 3025664

Molecular basis for heterogeneity of the human p53 protein.

N Harris, E Brill, O Shohat, M Prokocimer, D Wolf, N Arai, V Rotter.   

Abstract

The human p53 tumor antigen comprises several physically distinct proteins. Two p53 proteins, separable by polyacrylamide gel electrophoresis, are expressed by the human transformed cell line SV-80. The individual cDNAs which code for these proteins were isolated and constructed into the SP6 transcription vector. The proteins encoded by these clones were identified by in vitro transcription with the SP6 vector and translation in a cell-free system. p53-H-1 and p53-H-19 cDNA clones code for the faster- and slower-migrating p53 protein species, respectively, of SV-80. The in vitro-expressed proteins of p53-H-1 and p53-H-19 had the same antigenic determinants and were structurally indistinguishable from their in vivo counterparts. By expressing defined restricted cDNA fragments in vitro, the region of heterogeneity between the respective cDNAs was located at the 5' end of the cDNAs. Exchanging the 5' fragments of interest and expressing the chimeric clones in vitro confirmed that the DNA heterogeneity was responsible for the difference in the electrophoretic mobility of these proteins. The sequences of the two cDNAs revealed a single base pair difference (G versus C) in the coding region of the clones. This sequence difference resulted in an arginine being coded for in clone p53-H-1 and a proline being coded for at the equivalent position in clone p53-H-19. This variation accounted for the change in the electrophoretic mobility of the individual p53 protein species.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025664      PMCID: PMC367250          DOI: 10.1128/mcb.6.12.4650-4656.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Immunologically distinct p53 molecules generated by alternative splicing.

Authors:  N Arai; D Nomura; K Yokota; D Wolf; E Brill; O Shohat; V Rotter
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

5.  Different forms of p53 detected by monoclonal antibodies in non-dividing and dividing lymphocytes.

Authors:  J Milner
Journal:  Nature       Date:  1984 Jul 12-18       Impact factor: 49.962

6.  Phenotypic expression in Escherichia coli and nucleotide sequence of two Chinese hamster lung cell cDNAs encoding different dihydrofolate reductases.

Authors:  P W Melera; J P Davide; C A Hession; K W Scotto
Journal:  Mol Cell Biol       Date:  1984-01       Impact factor: 4.272

7.  Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo.

Authors:  M Kozak
Journal:  Nature       Date:  1984 Mar 15-21       Impact factor: 49.962

8.  Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.

Authors:  D Wolf; N Harris; V Rotter
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

9.  Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequences.

Authors:  D Wolf; V Rotter
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

10.  Analysis of the gene coding for the murine cellular tumour antigen p53.

Authors:  B Bienz; R Zakut-Houri; D Givol; M Oren
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

View more
  49 in total

Review 1.  Single-nucleotide polymorphisms in the p53 signaling pathway.

Authors:  Lukasz F Grochola; Jorge Zeron-Medina; Sophie Mériaux; Gareth L Bond
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

2.  Functional analysis of the p53 codon 72 polymorphism in black South Africans with rheumatoid arthritis--a pilot study.

Authors:  Devapregasan Moodley; Girish M Mody; Anil A Chuturgoon
Journal:  Clin Rheumatol       Date:  2010-06-10       Impact factor: 2.980

3.  p53 shares an antigenic determinant with proteins of 92 and 150 kilodaltons that may be involved in senescence of human cells.

Authors:  S J van den Heuvel; S I The; B Klein; A G Jochemsen; A Zantema; A J van der Eb
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis.

Authors:  G Shaulsky; N Goldfinger; A Ben-Ze'ev; V Rotter
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

5.  Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.

Authors:  Su-Qin Shen; De-Ke Jiang; Guo-Yuan Liu; Fang Chen; Long Yu
Journal:  Mol Biol Rep       Date:  2011-09-28       Impact factor: 2.316

6.  A DNA binding domain is contained in the C-terminus of wild type p53 protein.

Authors:  O S Foord; P Bhattacharya; Z Reich; V Rotter
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

7.  TP53 codon 72 polymorphism and glioma risk: A meta-analysis.

Authors:  Minghan Shi; Ruishan Huang; Chunying Pei; Xiuzhi Jia; Chuanlu Jiang; Huan Ren
Journal:  Oncol Lett       Date:  2011-12-12       Impact factor: 2.967

8.  An apoptotic defect in lens differentiation caused by human p53 is rescued by a mutant allele.

Authors:  T Nakamura; J G Pichel; L Williams-Simons; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

9.  The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription.

Authors:  X Liu; C W Miller; P H Koeffler; A J Berk
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

10.  P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.

Authors:  J Yeargin; J Cheng; A L Yu; R Gjerset; M Bogart; M Haas
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.